Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
Clinical trial NCT00183898 · COMPLETED
Trial details
- NCT number
- NCT00183898
- Sponsor
- University of Southern California
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-28
- Primary completion
- 2013-02-04
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.